Introduction: Polypharmacy, use of multiple medications has become a public health issue and is associated with increased risk of hospitalization, adverse drug reaction, reduced medication adherence, increased health care costs and reduced functional ability. There is an increasing risk of adverse effects, across population health. Polypharmacy can enhance the risk of kidney insufficiency, potentially due to several pharmacological metabolites, impact on renal physiology, health and metabolism. Aim: This research will examine correlation of polypharmacy on renal function in suspect/ high risk patients.

This audio/ podcast provides an excerpt surrounding CKD and Polypharmacy.

The Shientist - CKD and Polypharmacy (Da Excerpts Equipoise Chapter) (6)

Between 2005 and 2015, the percentage of individuals over 65 years of age in the UK rose by just over 20%. The age group that saw the greatest percentage increase was the over 85s, which increase by just under 33%, representing about 300,000 people. The number of people over the age of 85 years is projected to double between 2012 and 2032.This audio/ podcast provides an overview of a systematic review, which appraised literature surrounding influence of polypharmacy on renal insufficiency in older people and explored the following questions: Should there be smarter medicines management to reduce polypharmacy in older people? Can technology be used to determine who should be screened for renal insufficiency if ‘toxic drugs’ are overprescribed? What are the advantages of technology that incorporates algorithms in collaborative working? 

This audio/ podcast as part of this Interlude goes into Polypharmacy and Renal Insufficiency. Works was accepted for presentation at the Japanese Society of Nephrology (JSN) (2022)

Cataclysm Chiasma (Proxyl interlude)

Polypharmacy in Psychiatry (Medical Psychiatry Series Book 17)

Read Book : tq.filegood.club/B00UVACA3Y

This practical reference examines the advantages and disadvantages of polypharmacy in psychiatry, and provides up-to-date clinical guidelines on the appropriate use of combinations of pharmacological therapy in major psychiatric disorders-including multidisciplinary approaches to treatment, such as social work and psychopharmacology, and an examination of the psychotherapeutic and his

PDF Polypharmacy in Psychiatry (Medical Psychiatry Series Book 17) unlimited

In this special Complex Care Journal Club podcast episode, co-hosts Kristie Malik, Emily Goodwin and Kathleen Huth interview presenters of posters and oral abstracts relevant to the care of children with medical complexity at the Pediatric Academic Societies (PAS) 2024 annual meeting. Speakers describe the implications of their study findings, messages for patients and families, and priority areas for research that they hope can be investigated further by the complex care community in the coming years.

SPEAKERS
Mary Arakelyan, MPH
Research Project Manager
Dartmouth Health Children's
 
Tammie Dewan, MD, MSc
Clinical Assistant Professor
Department of Pediatrics, University of Calgary
Pediatrician, Alberta Children's Hospital
 
Caleb Easterly, BA
MD/PhD Student
University of North Carolina School of Medicine
 
Kevin Huynh, MS
Medical Student
University of Pittsburgh School of Medicine
 
Ruchi Kaushik, MD, MEd, MPH
Medical Director of Education and Research
Imagine Pediatrics, Houston TX
 
Joanna Leyenaar, MD, PhD
Professor, Department of Pediatrics
Dartmouth Health Children's﻿
 
Savithri Nageswaran, MD, MPH
Professor, Department of Pediatrics
Wake Forest University School of Medicine
 
Julia Reedy, MA
Qualitative Analyst
ACCORDS, University of Colorado

S. Margaret Wright, MD, MPH
Clinical Assistant Professor of Pediatrics
University of Missouri-Kansas City School of Medicine

Justin Yu, MD, MS
Assistant Professor of Pediatrics
UPMC Children’s Hospital of Pittsburgh

HOSTS
Kristina Malik, MD
Pediatrician, Special Care Clinic,
Children's Hospital Colorado

Emily J Goodwin, MD
Pediatrician, General Academic Pediatrics Beacon Program
Children’s Mercy Kansas City

Kathleen Huth, MD, MMSc
Pediatrician, Complex Care Service, Division of General Pediatrics
Boston Children's Hospital

DATE
Initial publication: May 15, 2024.

REFERENCES
Fehlings D, Agnew B, Gimeno H, Harvey A, Himmelmann K, Lin JP, Mink JW, Monbaliu E, Rice J, Bohn E, Falck-Ytter Y. Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update. Dev Med Child Neurol. 2024 Apr 19. doi: 10.1111/dmcn.15921. Epub ahead of print. PMID: 38640091. 

Pediatric Academic Societies. Who we are. Accessed May 6, 2024. https://www.pas-meeting.org/about/

TRANSCRIPT


Clinicians across healthcare professions, advocates, researchers, and patients/families are all encouraged to engage and provide feedback! You can recommend an article for discussion using this form: forms.gle/Bdxb86Sw5qq1uFhW6

Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children’s Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access, thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu

CITATION
Malik K, Goodwin EJ, Arakelyan M, Dewan T, Easterly C, Huynh K, Kaushik R, Leyenaar J, Nageswaran S, Reedy J, Wright SM, Yu J, Huth K. Practice-Changing Research in Complex Care at the Pediatric Academic Societies 2024 Annual Meeting. 5/2024. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/practice-changing-research-in-complex-care-at-the-pediatric-academic-societies-2024-annual-meeting

Practice-Changing Research in Complex Care at the Pediatric Academic Societies 2024 Annual Meeting

Zana Carver, PhD, is an associate professor with expertise in physiology, toxicology, and pharmacokinetics. In this episode, using thyroid issues as an example, Dr. Carver explains that the medical industry intentionally develops tests that lead to a failure to diagnose root medical problems, allowing multiple symptoms to develop, leading to perpetual polypharmacy.

Reference Links
https://informedchoicewa.substack.com/

Informed Life Radio 12 - 27 - 24 Health Hour - The Root Cause of Polypharmacy

Audio from our webinar held on the 4 March 2025 which featured a facilitated case-based discussion about the complexities of polypharmacy and deprescribing. This was a follow on from our first webinar, which lays the foundations of some of the deprescribing tools available. (57m02s)

Speakers: 
Lelly Oboh: Older people lead, NHS SPS
Jasvir Singh Dhillon: Clinical pharmacist, Shropshire, Telford & Wrekin ICB, & GP practices
Rakhi Aggarwal: Primary care lead, NHS SPS

Primary care discussions: personalised evidence-based medicine to minimise polypharmacy

ZtormLabostix Productions is all about Science in Healthcare. Sharing Scientific and Evidence-Based Practices through ZtormLabostix Sound Cloud. Collaborations include: The Renal Patient Support Group (RPSG) and The Kidney Disease and Renal Support (KDARs) Group for Kids

Alternative Talk 1150AM is unlike any other talk radio format in the Seattle Radio Market. Hosts on the station cover a wide variety of topics, including natural health, personal and financial growth, pet wellness, the psychic realm, issues important to today’s busy woman, and even foreign language programming to serve the area’s large Russian and Chinese speaking communities. Alternative Talk 1150 is proud to pioneer such unique and diverse talk radio subjects. The station brings a variety of perspectives to the Puget Sound airwaves with talk radio that touches on seldom covered subject matter.

NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines.  Our motto is 'do once and share'.

New tracks tagged #polypharmacy